OptimizeRx Corp Files 8-K on Financials

Ticker: OPRX · Form: 8-K · Filed: May 12, 2025 · CIK: 1448431

Optimizerx CORP 8-K Filing Summary
FieldDetail
CompanyOptimizerx CORP (OPRX)
Form Type8-K
Filed DateMay 12, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: financial-reporting, 8-k

Related Tickers: OPRX

TL;DR

OptimizeRx filed an 8-K on May 12, 2025, detailing its financial condition and results of operations.

AI Summary

OptimizeRx Corp filed an 8-K on May 12, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company incorporated in Nevada and headquartered in Waltham, MA.

Why It Matters

This 8-K filing provides an update on OptimizeRx Corp's financial performance and condition, which is crucial information for investors and stakeholders to assess the company's health and future prospects.

Risk Assessment

Risk Level: low — This is a routine financial filing (8-K) and does not appear to contain any new material events or negative developments.

Key Players & Entities

FAQ

What specific financial information is being reported in this 8-K filing?

The filing is categorized under 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', indicating it contains updates on the company's financial performance and related documentation.

When was this 8-K report filed?

The report was filed on May 12, 2025.

Where is OptimizeRx Corporation's principal executive office located?

The principal executive offices are located at 260 Charles Street, Suite 302, Waltham, MA 02453.

In which state was OptimizeRx Corporation incorporated?

OptimizeRx Corporation was incorporated in Nevada.

What is the IRS Employer Identification Number for OptimizeRx Corp?

The IRS Employer Identification Number for OptimizeRx Corp is 26-1265381.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 12, 2025 regarding OptimizeRx Corp (OPRX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing